| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ILLUMINA, INC. | SVP, Chief Commercial Officer | Common Stock | 36.9K | $4.04M | $109.65 | Jul 5, 2024 | Direct |
| EXACT SCIENCES CORP | Chief Commercial Officer | Common Stock | 47K | $2.83M | $60.15 | May 1, 2024 | Direct |
| EXACT SCIENCES CORP | Chief Commercial Officer | Restricted Stock Units | 15.9K | $942K | $59.32 | Feb 29, 2024 | Direct |
| ARVINAS, INC. | Director | Common Stock | 10K | $471K | $47.05 | May 29, 2024 | Direct |
| ILLUMINA, INC. | SVP, Chief Commercial Officer | Common Stock | 3.15K | $346K | $109.65 | Jul 5, 2024 | Revocable Trust |
| ARVINAS, INC. | Director | Stock Option (right to buy) | 9.07K | $145K | $16.00 | May 29, 2024 | Direct |
| ILLUMINA, INC. | SVP, Chief Commercial Officer | Common Stock | 757 | $83K | $109.65 | Jul 5, 2024 | IRA |
| ILLUMINA, INC. | SVP, Chief Commercial Officer | Common Stock | 672 | $73.7K | $109.65 | Jul 5, 2024 | Spouse IRA |
| EXACT SCIENCES CORP | Chief Commercial Officer | Common Stock | 571 | $34.3K | $60.15 | Apr 30, 2024 | Held in 401(k) Plan |
| ILLUMINA, INC. | SVP, Chief Commercial Officer | Common Stock | 70 | $7.68K | $109.65 | Jul 5, 2024 | Beneficiary IRA |
| ILLUMINA, INC. | SVP, Chief Commercial Officer | Performance Shares | 18.4K | Jul 5, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ILMN | ILLUMINA, INC. | Jul 5, 2024 | 3 | $0 | 4 | Jul 9, 2024 | SVP, Chief Commercial Officer |
| ILMN | ILLUMINA, INC. | Jun 10, 2024 | 0 | $0 | 3 | Jun 20, 2024 | SVP, Chief Commercial Officer |
| ARVN | ARVINAS, INC. | May 29, 2024 | 2 | $0 | 4 | May 31, 2024 | Director |
| EXAS | EXACT SCIENCES CORP | Apr 30, 2024 | 3 | $13.1K | 4 | May 2, 2024 | Chief Commercial Officer |
| EXAS | EXACT SCIENCES CORP | Feb 29, 2024 | 3 | -$143K | 4 | Mar 4, 2024 | Chief Commercial Officer |
| EXAS | EXACT SCIENCES CORP | Feb 26, 2024 | 4 | -$208K | 4 | Feb 28, 2024 | Chief Commercial Officer |
| EXAS | EXACT SCIENCES CORP | Feb 21, 2024 | 2 | -$80.7K | 4 | Feb 23, 2024 | Chief Commercial Officer |
| EXAS | EXACT SCIENCES CORP | Oct 11, 2023 | 6 | -$844K | 4 | Oct 13, 2023 | Chief Commercial Officer |
| ARVN | ARVINAS, INC. | Jun 15, 2023 | 2 | $0 | 4 | Jun 20, 2023 | Director |
| EXAS | EXACT SCIENCES CORP | Mar 1, 2023 | 1 | -$225K | 4 | Mar 2, 2023 | Chief Commercial Officer |
| EXAS | EXACT SCIENCES CORP | Feb 27, 2023 | 2 | $0 | 4 | Mar 1, 2023 | Chief Commercial Officer |
| EXAS | EXACT SCIENCES CORP | Feb 24, 2023 | 1 | $0 | 4 | Feb 28, 2023 | Chief Commercial Officer |
| ARVN | ARVINAS, INC. | Dec 15, 2022 | 1 | $0 | 4 | Dec 19, 2022 | Director |
| ARVN | ARVINAS, INC. | Dec 15, 2022 | 0 | $0 | 3 | Dec 19, 2022 | Director |
| EXAS | EXACT SCIENCES CORP | Oct 11, 2022 | 6 | -$505K | 4 | Oct 13, 2022 | Chief Commercial Officer |
| EXAS | EXACT SCIENCES CORP | Feb 25, 2022 | 1 | $0 | 4 | Mar 1, 2022 | Chief Commercial Officer |
| EXAS | EXACT SCIENCES CORP | Nov 1, 2021 | 0 | $0 | 3 | Nov 5, 2021 | Chief Commercial Officer |